← Back to Search

PDL + Fractional Photothermolysis for Scarring

N/A
Waitlist Available
Led By Murad Alam, MD
Research Sponsored by Northwestern University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and 6 months
Awards & highlights

Study Summary

This trial is evaluating the efficacy of early combined PDL (pulsed dye laser) and fractional photothermolysis in the cosmetic improvement of post surgical scars. Subjects will have the choice of whether or not they will receive treatment in part A, and subjects will be randomized in a 2:1 treatment vs. control design in part B.

Who is the study for?
This trial is for adults over 18 in good health who have had dermatologic surgery on their trunk or limbs and are healing with a specific type of suture. They must not be pregnant, breastfeeding, prone to severe scarring, or have certain skin infections. Participants should live near Chicago and stop using topical retinoids one week before treatment.Check my eligibility
What is being tested?
The study tests the effectiveness of combining two laser treatments (PDL and fractional photothermolysis) on improving the appearance of post-surgical scars. Part A lets subjects choose to receive treatment; Part B randomly assigns them to either get treated or serve as controls in a 2:1 ratio.See study design
What are the potential side effects?
Potential side effects from the laser treatments may include redness, swelling, bruising at the treated area, changes in skin pigmentation, discomfort during the procedure, and rare chances of scarring.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and 6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in score of Patient and Observer Scar Assessment Scale (POSAS)

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: PDL (Pulsed Dye Laser) and Fractional PhotothermolysisExperimental Treatment2 Interventions
Group II: ControlActive Control1 Intervention

Find a Location

Who is running the clinical trial?

Northwestern UniversityLead Sponsor
1,585 Previous Clinical Trials
917,081 Total Patients Enrolled
Murad Alam, MDPrincipal InvestigatorNorthwestern University
69 Previous Clinical Trials
2,430 Total Patients Enrolled

Media Library

PDL (Pulsed Dye Laser) Clinical Trial Eligibility Overview. Trial Name: NCT03057964 — N/A
Scarring Research Study Groups: Control, PDL (Pulsed Dye Laser) and Fractional Photothermolysis
Scarring Clinical Trial 2023: PDL (Pulsed Dye Laser) Highlights & Side Effects. Trial Name: NCT03057964 — N/A
PDL (Pulsed Dye Laser) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03057964 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~11 spots leftby Dec 2024